Dark Chocolate Mood and PEA
The cultural mythology that dark chocolate is a "love food" or "happiness food" is real but built on thinner physiology than the marketing implies. Cocoa contains beta-phenylethylamine (PEA), an endogenous trace amine released by the brain during attraction and elevated mood — but dietary PEA is largely degraded by monoamine oxidase B (MAO-B) in the gut wall before reaching the brain, so the chocolate-as-love-drug story is more elegant than functional. The genuine mood mechanisms in dark chocolate are different: the methylxanthines theobromine and caffeine, which block adenosine receptors (in one controlled trial the mood gains came from the caffeine), anandamide and N-acyl-ethanolamine signaling at cannabinoid receptors (small doses, plausible contribution), tryptophan and tyrosine as precursors for serotonin and dopamine (modest contribution at typical chocolate doses), and the well-documented hedonic-reward response to highly palatable food regardless of specific neuroactive content. This page walks through each mechanism honestly, distinguishes what the science actually supports from what marketing claims, and lands on a practical synthesis: dark chocolate genuinely modestly improves mood in short-term experiments, but mainly through the methylxanthine pharmacology, the placebo and pleasure response, and the broader cardiovascular-cognitive benefit — not through dietary PEA crossing into the brain.
Table of Contents
- PEA: The Mythology and the Inconvenient Pharmacokinetics
- Theobromine: The Dominant Methylxanthine
- Anandamide and the Cannabinoid System
- Tryptophan, Tyrosine, and Monoamine Precursors
- Cocoa Flavanols and Cognition
- What Mood Trials Actually Show
- The Hedonic-Reward Component
- Pre-Menstrual Chocolate Cravings: What the Research Says
- Dark Chocolate, Depression, and Anxiety
- Cautions and Limits of the Evidence
- Key Research Papers
- Connections
- Featured Videos
PEA: The Mythology and the Inconvenient Pharmacokinetics
Beta-phenylethylamine (PEA, sometimes written as 2-phenylethylamine) is an endogenous trace amine produced in the brain by decarboxylation of L-phenylalanine. Brain PEA acts as a neuromodulator that potentiates dopaminergic and noradrenergic signaling. Endogenous brain PEA levels rise during attraction, romantic love, exercise, certain types of exhilaration, and the manic phase of bipolar disorder. PEA is also one of the structural building blocks of stimulant drugs (amphetamine and its derivatives are substituted phenylethylamines).
Cocoa contains at most small amounts of dietary PEA, and measured amounts vary between studies and samples: a 2005 Italian analysis of biogenic amines in chocolate (Pastore et al.) found dopamine, histamine and serotonin in its chocolate samples, but no 2-phenylethylamine above the method's detection limit of 3 mg per kg (0.3 mg per 100 g).
The chocolate-as-love-food cultural story rests on the assertion that dietary PEA from chocolate raises brain PEA and produces the mood and attraction effects of endogenous brain PEA. This assertion fails three rigorous tests:
- Gut-wall monoamine oxidase B degrades dietary PEA before systemic absorption. PEA is an excellent MAO-B substrate, and the intestinal mucosa contains substantial MAO-B activity. The vast majority of an oral PEA dose is deaminated to phenylacetic acid within the gut wall before reaching the portal circulation.
- What little PEA reaches portal circulation is largely cleared by hepatic first-pass metabolism. Liver MAO-A and MAO-B further degrade circulating PEA. Systemic plasma PEA after a typical dietary dose is essentially indistinguishable from baseline.
- Oral PEA has been studied for mood only together with an MAO-B inhibitor. The Sabelli group gave depressed patients 10-60 mg of oral PEA a day with 10 mg a day of the MAO-B inhibitor selegiline to prevent rapid PEA destruction; when 14 patients who had responded were re-examined 20 to 50 weeks later, 12 still had the antidepressant response. This relied on active MAO-B inhibition — conditions not present with dietary chocolate alone, where PEA is broken down quickly.
The honest summary: dietary PEA from chocolate does not meaningfully cross into the brain in the absence of MAO-B inhibition. The cultural story of chocolate as a "love chemical" is a real cultural fact and a thin physiological one. The mood effect from chocolate consumption is real but mechanistically operates through other pathways discussed below, not through PEA.
(Some patients on irreversible MAO-B inhibitors for Parkinson's disease — selegiline, rasagiline — may experience genuinely enhanced PEA effects from dietary sources including chocolate. The interaction is well documented but rarely clinically problematic. The MAO-A inhibitors used for atypical depression are a different concern because of the tyramine reaction, but the PEA in chocolate is not the relevant amine for that interaction.)
Theobromine: The Dominant Methylxanthine
Dark chocolate carries far more of two methylxanthines, theobromine and caffeine, than of PEA: USDA FoodData Central lists 802 mg theobromine and 80 mg caffeine per 100 g of 70-85% dark chocolate. In the Mitchell 2011 trial the mood gains came from caffeine, while theobromine given alone decreased calmness. Theobromine and caffeine are both methylxanthines with similar mechanisms but different kinetics.
Theobromine pharmacology:
- Mechanism — competitive antagonism at adenosine A1 and A2A receptors (the mechanism shared with caffeine), plus weak inhibition of phosphodiesterases. The adenosine antagonism reduces the inhibitory tone that adenosine normally exerts on dopaminergic and cholinergic neurons, producing mild stimulation of these systems.
- Half-life — approximately 7-12 hours in humans (compared with caffeine's 4-6 hours). The longer half-life produces a more sustained, gentler stimulant character.
- Onset — approximately 30-60 minutes after consumption, slower than caffeine's 15-30 minute onset. The effect builds gradually rather than spiking.
- Subjective character — smoother, less jittery than caffeine, with less vasoconstriction and less tendency to produce anxiety. The lower central nervous system (CNS) stimulant intensity is a feature, not a bug.
- Mild vasodilation — theobromine produces modest peripheral vasodilation (in contrast to caffeine's vasoconstriction in the cerebral circulation), which may contribute to the warming sensation associated with dark chocolate consumption.
- Mild diuresis — theobromine is a mild diuretic. Heavy daily chocolate consumption can modestly increase urine output.
The Mitchell et al. 2011 paper in Physiology & Behavior directly compared theobromine alone (700 mg), caffeine alone (120 mg), the combination, and placebo in 24 healthy women. Theobromine alone lowered blood pressure 1 hour after ingestion but decreased self-rated calmness at 3 hours; caffeine raised self-rated alertness and contentedness; the combination had mood effects similar to caffeine alone, with no effect on blood pressure. The authors tentatively concluded that caffeine acts mainly on alertness through the brain, while theobromine may act mainly through changes elsewhere in the body. The Smit, Gaffan, and Rogers 2004 paper in Psychopharmacology found that the amounts of caffeine and theobromine in a 50 g dark-chocolate bar produced the same improvement in "energetic arousal" mood and in cognitive function as the cocoa powder itself, concluding that the psychopharmacological activity of chocolate is confined to the caffeine-theobromine combination, with the other neuroactive components contributing only marginally at typical dietary doses.
The practical implication is that dark chocolate is best understood pharmacologically as a gentler, more sustained-release alternative to coffee, with the cocoa flavanols and minerals as cardiovascular and metabolic add-ons. The 7-12 hour theobromine half-life means that mid-afternoon dark chocolate consumption can disrupt sleep for sensitive individuals.
Anandamide and the Cannabinoid System
The 1996 Nature paper by di Tomaso, Beltramo, and Piomelli identified that cocoa contains three lipid molecules with biological activity at the cannabinoid receptor system: anandamide (the prototypical endogenous cannabinoid, N-arachidonoylethanolamine), and two related N-acyl-ethanolamines (N-oleoylethanolamine and N-linoleoylethanolamine). Anandamide itself binds the CB1 and CB2 cannabinoid receptors; the N-acyl-ethanolamines inhibit FAAH (fatty acid amide hydrolase), the enzyme that degrades endogenous anandamide.
The mechanism is conceptually elegant: cocoa contains both the active ligand and the enzyme inhibitor that prolongs the ligand's half-life. The doses, however, are very small. The anandamide content of cocoa is approximately 50-60 ng per gram — meaning a 30 g serving delivers approximately 1.5-2 mcg of anandamide. The N-acyl-ethanolamine content is similarly small.
For comparison, the endogenous anandamide production rate in a typical adult is in the range of mg/day. Dietary anandamide from chocolate is roughly 1,000-fold smaller than endogenous production. Whether this 0.1% perturbation produces a meaningful pharmacologic effect at cannabinoid receptors is doubtful. The contribution of the FAAH-inhibiting N-acyl-ethanolamines to extending endogenous anandamide signaling is somewhat more plausible but also small.
The honest summary: cocoa contains genuine endocannabinoid-system ligands, the doses are small, and any contribution to mood from this pathway is at the margin. The 1996 Nature paper that put this on the cultural map was a genuine and elegant scientific discovery, but the popular framing that "chocolate produces cannabis-like effects" substantially over-reads what the doses can do.
Tryptophan, Tyrosine, and Monoamine Precursors
Cocoa is a modest source of the aromatic amino acids tryptophan and tyrosine. Tryptophan is the precursor to serotonin (via 5-hydroxytryptophan); tyrosine is the precursor to dopamine, norepinephrine, and epinephrine (via L-DOPA). The brain's synthesis of these monoamines is partly dependent on plasma availability of the precursor amino acids.
The numbers are small. A 30 g serving of dark chocolate provides approximately 50 mg tryptophan and 100 mg tyrosine. By comparison, a 30 g serving of pumpkin seeds provides ~170 mg tryptophan; a 3 oz serving of turkey provides ~250 mg tryptophan; a 3 oz serving of beef provides ~400 mg tyrosine. Dark chocolate is a minor amino acid source.
The classic story that "eating tryptophan-rich foods boosts serotonin" is itself substantially overstated — the actual rate-limiting step for brain serotonin synthesis is more closely tied to the ratio of tryptophan to other large neutral amino acids (LNAA) crossing the blood-brain barrier than to total dietary tryptophan. A pure-carbohydrate meal raises this ratio (via insulin clearing the competing LNAA) more effectively than a tryptophan-rich protein meal.
The honest assessment: cocoa's amino acid contribution to mood is small relative to the methylxanthine pharmacology and the hedonic-reward response. The "chocolate raises serotonin via tryptophan" story is real but quantitatively modest.
Cocoa Flavanols and Cognition
The cocoa flavanol benefit story extends to mood and cognition in part because of the cerebrovascular effect — flavanols dilate cerebral arteries, raise cerebral blood flow, and modestly improve cognitive performance, particularly in older adults and in cognitively-demanding tasks under stress.
- Brickman et al. 2014 (Nature Neuroscience) showed that a 3-month intervention with high-flavanol cocoa drink in healthy older adults produced measurable improvement in dentate-gyrus-dependent memory tasks, parallel to improvement in cerebral blood flow to that brain region.
- Scholey AB et al. reported acute improvements in cognitive performance (serial subtraction, rapid visual information processing) within 2 hours of cocoa flavanol drink in healthy young adults, with parallel improvements in self-rated mental fatigue.
- Sokolov AN et al. 2013 reviewed cocoa flavanol effects on neurobiology, concluding that the evidence for cerebrovascular and cognitive benefit is more robust than for mood effects specifically.
- Pase MP et al. reported modest mood improvement (positive affect, fatigue reduction) but not cognitive performance improvement after chronic cocoa flavanol intake in healthy adults.
- COSMOS-Mind (2023) found that 3 years of cocoa extract (500 mg flavanols a day) had no effect on global cognition in 2,262 older adults (mean age 73) tested by telephone; the memory and executive-function benefits in that trial came from its multivitamin arm, not the cocoa extract. The COSMOS clinic sub-study (573 older adults, in-person testing over 2 years) also found no effect of cocoa extract on global cognition, memory or executive function.
- COSMOS-Web (Brickman et al. 2023), in 3,562 older adults taking 500 mg cocoa flavanols a day or placebo, did not improve memory in the whole group at 1 year (its main test), but memory did improve in participants whose usual diet was poorest or lowest in flavanols.
The proposed mechanism: cocoa flavanols improve cerebrovascular function via the same endothelial nitric oxide synthase (eNOS) nitric-oxide pathway that operates in the peripheral vasculature. The brain benefit is partly direct (better-perfused brain regions perform better) and partly indirect (improved global cardiovascular function reduces cumulative microvascular brain injury over years).
The mood-specific effects of cocoa flavanols are smaller and more heterogeneous than the cognitive effects. Some trials report meaningful mood improvement, others find no significant effect. The summary is that flavanols contribute mildly to mood through the cerebrovascular pathway, but the dominant short-term mood effect of dark chocolate is the methylxanthine pharmacology and hedonic reward.
What Mood Trials Actually Show
A series of controlled trials have measured short-term mood response to chocolate or cocoa consumption versus placebo. The general pattern:
- Macht and Mueller 2007 (Appetite) showed that 12.5 g of palatable chocolate (vs. unpalatable chocolate or no food) produced significant short-term improvement in negative mood in induced sad mood states. The improvement was largely abolished when participants disliked the chocolate. This indicates a palatability/hedonic-reward effect rather than a pharmacologic effect of any specific cocoa constituent.
- Parker, Parker, Brotchie 2006 (J Affect Disord) reviewed chocolate and mood interactions, concluding that mood-driven chocolate consumption (the seeking of palatable food during dysphoric mood) is well-documented, while pharmacologic mood improvement from chocolate is small and short-lived.
- Pase MP et al. 2013 reported that 4 weeks of daily cocoa polyphenol intake improved self-rated calmness and contentment in healthy adults, without parallel improvement in cognitive performance.
- COSMOS-Mind 2023 did not measure mood; it found no cognitive benefit from 3 years of cocoa extract (500 mg flavanols a day) in 2,262 older adults.
- Mitchell et al. 2011 directly compared methylxanthines in 24 healthy women: the mood gains (alertness, contentedness) came from caffeine, theobromine alone decreased self-rated calmness, and the combination matched caffeine alone.
- Fusar-Poli et al. 2022 pooled 9 studies in a meta-analysis: cocoa-rich products improved depressive symptoms, anxiety, and positive and negative mood, with medium-sized effects (Hedges' g −0.42 for depressive symptoms, −0.49 for anxiety). Five of the studies tested a single dose and only two lasted more than a week, and few people took part, so the authors write that the results cannot be applied to long-term eating.
- Shin et al. 2022: in a 3-week trial in 48 healthy adults aged 20-30, 30 g a day of 85% cocoa chocolate lowered negative mood scores, while 70% cocoa chocolate did not. The 85% group also had more varied gut bacteria than the no-chocolate group, which the authors link to mood through the gut-brain axis.
The honest synthesis: dark chocolate produces a small but real short-term mood improvement that compounds three contributions of similar magnitude:
- Methylxanthine pharmacology (theobromine + caffeine; the largest single contributor)
- Hedonic reward from palatable food (well-documented even for non-chocolate palatable foods)
- Modest cerebrovascular and possibly endocannabinoid effects (smaller contributors)
The PEA story, in contrast, has essentially no empirical support beyond the cultural narrative. PEA from dietary chocolate does not reach the brain at meaningful concentrations.
The Hedonic-Reward Component
One of the most consistent findings in chocolate-and-mood research is that the mood benefit depends substantially on whether the participant enjoys the chocolate. In Macht and Mueller's 2007 work (48 adults in a first experiment, 113 in a second), a piece of chocolate lifted a sad mood brought on by a film clip; palatable chocolate improved mood while unpalatable chocolate produced no significant mood improvement — despite delivering the same pharmacologic load of theobromine, caffeine, flavanols, and PEA — and the lift was gone after 3 minutes.
This is the hedonic-reward component, mediated by the brain's mesolimbic dopamine system. The anticipation, consumption, and post-consumption pleasure of a highly palatable food activates the ventral tegmental area, nucleus accumbens, and related reward circuitry. The dopamine release produces the immediate "mood lift" that is the most subjectively obvious effect of chocolate consumption. This effect is non-specific — any food that the eater enjoys produces a similar mesolimbic activation. Chocolate is exceptionally good at this because of its texture (cocoa butter melts precisely at body temperature, producing a unique melt-in-mouth sensation), its flavor complexity, its cultural associations, and its calorie density (the mesolimbic system evolved to reward high-energy foods).
The implications:
- Eating chocolate you genuinely enjoy produces real mood benefit. This is not "just placebo" — it is a real neurobiological effect of pleasure perception.
- Eating chocolate you do not enjoy produces little mood benefit, regardless of the cocoa content.
- The mood improvement from palatable chocolate is short-lived: in Macht and Mueller's experiment it had disappeared after 3 minutes, consistent with a hedonic-reward response. The longer-term methylxanthine effect persists for several hours.
- The mood-improving effect of chocolate, like other palatable foods, can drive overconsumption when used as a coping mechanism for chronic negative affect. The pattern of using chocolate as emotional self-medication is common and not benign at the population level — it contributes to weight gain and to the substitution of food rewards for needed lifestyle, social, or psychological interventions.
Pre-Menstrual Chocolate Cravings: What the Research Says
The frequently-reported cultural pattern of pre-menstrual chocolate craving in women is real (consistent across surveys; approximately 30-50% of menstruating women in Western countries report increased chocolate craving in the late luteal phase). The mechanism is less clear and probably multi-causal:
- Magnesium hypothesis — pre-menstrual magnesium status drops modestly with the late-luteal progesterone increase, and chocolate is a magnesium-rich food. The body's craving for magnesium could partially explain the chocolate-specific pattern. Empirical support is weak.
- Serotonin hypothesis — the same late-luteal progesterone increase reduces serotonin synthesis, contributing to pre-menstrual dysphoria. Carbohydrate-rich foods (including chocolate) raise the tryptophan-to-LNAA ratio crossing the blood-brain barrier and transiently increase brain serotonin synthesis. This is a general carbohydrate effect, not chocolate-specific.
- Cultural conditioning — in cross-cultural comparison, the chocolate-craving pattern is much stronger in Western countries than in countries where chocolate is not the culturally-defined comfort food. In a study of chocolate cravers, 60% of American women but 24% of Spanish women said their cravings came around their period when asked directly (40% vs 4% when asked an open question), which the authors read as a cultural rather than a physiological origin. Egyptian and Japanese women are also reported to have pre-menstrual cravings of similar magnitude but for different specific foods; a craving survey of 185 Japanese female college students found rice and sushi among the main craved foods. This suggests that the chocolate-specificity is partly learned, not entirely biological.
- Hedonic-reward mechanism — during pre-menstrual dysphoric mood, the brain seeks reliable mood-improving stimuli. Chocolate is reliably mood-improving for most women, so it gets sought.
In summary: pre-menstrual chocolate craving is a real phenomenon, the mechanism is multi-factorial, and modest consumption (one ounce of high-cacao dark chocolate) is unlikely to cause meaningful harm and may genuinely improve dysphoric mood. The pattern becomes problematic only when it escalates to consumption levels that cause weight gain or takes the place of other pre-menstrual symptom approaches (exercise, sleep, magnesium supplementation, and in some cases selective serotonin reuptake inhibitor (SSRI) luteal-phase dosing for severe premenstrual dysphoric disorder (PMDD)).
Dark Chocolate, Depression, and Anxiety
The question of whether dark chocolate has clinical utility in depression and anxiety has been studied in several small trials with mixed results. The general findings:
- Several short-term trials in subclinical and mild depression report modest improvement in mood scales with daily dark chocolate or cocoa flavanol intake compared with placebo. A 2022 meta-analysis of 9 studies found medium-sized short-term effects on depressive symptoms (Hedges' g −0.42), from short trials with few participants.
- The benefit is comparable to other small dietary interventions (e.g., increased omega-3 intake, increased fruit and vegetable intake) and substantially smaller than evidence-based psychotherapy or pharmacologic treatment for moderate-to-severe depression.
- The benefit is most consistent in older adults, where the cerebrovascular mechanism is most plausible — cocoa flavanols may improve mood partly by improving general brain perfusion in adults with subclinical microvascular brain dysfunction.
- For anxiety, the same 2022 meta-analysis found a similar medium-sized short-term reduction (Hedges' g −0.49), also from few, short trials.
- In a US survey of 13,626 adults (2007-2014), people whose two 24-hour food recalls included dark chocolate had 70% lower odds of clinically relevant depressive symptoms (odds ratio 0.30), although only 1.4% reported eating dark chocolate. A one-time survey cannot show cause and effect.
The honest synthesis: dark chocolate produces short-term mood benefits in subclinical and mild depression, but the trials are too short and too small to show that it can stand in for depression treatment. The established interventions studied for significant depressive or anxiety symptoms are psychotherapy, exercise, light therapy where seasonal, and medicines. In the research, dark chocolate is at most a complementary dietary adjunct.
For people with subclinical or non-pathological negative mood (the routine "had a hard day" experience), a small portion of high-cacao dark chocolate is a culturally common mood-improving food. The improvement is real, even if its mechanism is largely the methylxanthine pharmacology and the hedonic-reward response rather than the more romantic PEA story.
Cautions and Limits of the Evidence
- Dark chocolate is not a substitute for evidence-based depression treatment. The mood effect is short-term and has not been shown to treat moderate-to-severe depression.
- The "chocolate as PEA / love drug" framing is mostly cultural mythology. Dietary PEA is degraded by gut-wall MAO-B before systemic absorption. The genuine mood mechanisms are methylxanthine pharmacology, hedonic reward, and (smaller) cerebrovascular and endocannabinoid pathways.
- Methylxanthine load matters for sleep. USDA lists 802 mg theobromine and 80 mg caffeine per 100 g of 70-85% dark chocolate, and theobromine's half-life is 7-12 hours. Mid-afternoon and later consumption can impair sleep for sensitive individuals.
- MAO-B inhibitor users (selegiline, rasagiline for Parkinson's) may experience enhanced effects from dietary PEA in chocolate. This is rarely clinically problematic but worth knowing.
- Selective serotonin reuptake inhibitor users who experience initial gastrointestinal (GI) upset may find dark chocolate worsens it during the first weeks of therapy.
- Emotional eating pattern. The use of palatable food (including chocolate) as a primary coping mechanism for chronic negative affect is a documented contributor to weight gain and to the avoidance of needed lifestyle and psychological interventions. Macht and Mueller suggest that the immediate mood lift from palatable food helps build the habit of eating to cope with stress; the concern in the research is this habitual pattern rather than occasional deliberate enjoyment.
- Children with attention-deficit/hyperactivity disorder (ADHD) — the methylxanthine load (caffeine plus theobromine) can interact unfavorably with stimulant medications. Afternoon and evening chocolate adds to the stimulant load of a child already taking stimulant medicine.
- Pregnancy — the standard guidance limits total daily caffeine during pregnancy to 200 mg; the caffeine in dark chocolate counts toward that total, and theobromine adds further methylxanthine load. The mood effect of one ounce is modest.
- Migraine patients — a subset identifies chocolate as a migraine trigger. The evidence for chocolate as an independent trigger is weaker than for cheese, red wine, or aged meats, but individual variation matters, and the trigger is identified person by person.
Key Research Papers
- di Tomaso E, Beltramo M, Piomelli D (1996). Brain cannabinoids in chocolate. Nature — PubMed PMID: 8751435
- Smit HJ, Gaffan EA, Rogers PJ (2004). Methylxanthines are the psycho-pharmacologically active constituents of chocolate. Psychopharmacology — PubMed PMID: 15549276
- Mitchell ES et al. (2011). Differential contributions of theobromine and caffeine on mood, psychomotor performance and blood pressure. Physiol Behav — PubMed PMID: 21839757
- Macht M, Mueller J (2007). Immediate effects of chocolate on experimentally induced mood states. Appetite — PubMed PMID: 17597253
- Parker G, Parker I, Brotchie H (2006). Mood state effects of chocolate. J Affect Disord — PubMed PMID: 16546266
- Pase MP et al. (2013). Cocoa polyphenols enhance positive mood states but not cognitive performance: a randomized, placebo-controlled trial. J Psychopharmacol — PubMed PMID: 23364814
- Scholey AB et al. (2010). Consumption of cocoa flavanols results in acute improvements in mood and cognitive performance during sustained mental effort. J Psychopharmacol — PubMed PMID: 19942640
- Brickman AM et al. (2014). Enhancing dentate gyrus function with dietary flavanols improves cognition in older adults. Nat Neurosci — PubMed PMID: 25344629
- Sokolov AN et al. (2013). Chocolate and the brain: neurobiological impact of cocoa flavanols on cognition and behavior. Neurosci Biobehav Rev — PubMed PMID: 23810791
- Sabelli HC et al. (1996). Sustained antidepressant effect of PEA replacement. J Neuropsychiatry Clin Neurosci — PubMed PMID: 9081552
- Pastore P, Favaro G, Badocco D, et al. (2005). Determination of biogenic amines in chocolate by ion chromatographic separation and pulsed integrated amperometric detection with implemented wave-form at Au disposable electrode. J Chromatogr A — PubMed PMID: 16314166
- Mumford GK et al. (1996). Absorption rate of methylxanthines following capsules, cola and chocolate. Eur J Clin Pharmacol — PubMed PMID: 9010706
- Mostofsky E et al. (2010). Chocolate intake and incidence of heart failure: a population-based prospective study of middle-aged and elderly women. Circ Heart Fail — PubMed PMID: 20713904
- Baker LD, Manson JE, Rapp SR, et al. (2023). Effects of cocoa extract and a multivitamin on cognitive function: A randomized clinical trial. Alzheimers Dement — PubMed PMID: 36102337
- Vyas CM, Manson JE, Sesso HD, et al. (2024). Effect of cocoa extract supplementation on cognitive function: results from the clinic subcohort of the COSMOS trial. Am J Clin Nutr — PubMed PMID: 38070683
- Brickman AM, Yeung LK, Alschuler DM, et al. (2023). Dietary flavanols restore hippocampal-dependent memory in older adults with lower diet quality and lower habitual flavanol consumption. Proc Natl Acad Sci U S A — PubMed PMID: 37252983
- Fusar-Poli L, Gabbiadini A, Ciancio A, et al. (2022). The effect of cocoa-rich products on depression, anxiety, and mood: A systematic review and meta-analysis. Crit Rev Food Sci Nutr — PubMed PMID: 33970709
- Shin JH, Kim CS, Cha J, et al. (2022). Consumption of 85% cocoa dark chocolate improves mood in association with gut microbial changes in healthy adults: a randomized controlled trial. J Nutr Biochem — PubMed PMID: 34530112
- Jackson SE, Smith L, Firth J, et al. (2019). Is there a relationship between chocolate consumption and symptoms of depression? A cross-sectional survey of 13,626 US adults. Depress Anxiety — PubMed PMID: 31356717
- Zellner DA, Garriga-Trillo A, Centeno S, Wadsworth E (2004). Chocolate craving and the menstrual cycle. Appetite — PubMed PMID: 15036792
- Komatsu S (2008). Rice and sushi cravings: a preliminary study of food craving among Japanese females. Appetite — PubMed PMID: 18006114
PubMed Topic Searches
Connections
- All Food
- Dark Chocolate Overview
- Dark Chocolate Benefits Hub
- Flavanols & Endothelial Function
- Iron, Magnesium & Mineral Content
- Cacao Percentage & Sugar
- Coffee (Methylxanthines)
- Green Tea (L-Theanine)
- Tryptophan
- Tyrosine
- Magnesium
- Depression
- Anxiety
- Migraine
- Parkinson's Disease
- Antioxidants
- History
- Nutrients